Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raghav Sundar

Showing results (121-130 of 149) with videos related to

Pageof 15
Sort By:
JAMA Oncology|July 13, 2023
COVID-19 Severity and Waning Immunity After up to 4 mRNA Vaccine Doses in 73 608 Patients With Cancer and 621 475 Matched Controls in Singapore: A Nationwide Cohort StudyWei Chong Tan, Janice Yu Jin Tan, Joline Si Jing Lim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2018
Real-Time Tumor Gene Expression Profiling to Direct Gastric Cancer Chemotherapy: Proof-of-Concept "3G" TrialWei Peng Yong, Sun Young Rha, Iain Bee-Huat Tan, et al.
Oncotarget|September 1, 2016
Phase Ib/II randomized, open-label study of doxorubicin and cyclophosphamide with or without low-dose, short-course sunitinib in the pre-operative treatment of breast cancerAndrea L A Wong, Raghav Sundar, Ting-Ting Wang, et al.
Therapeutic Advances in Medical Oncology|November 6, 2024
Unveiling the prognostic significance of malignant ascites in advanced gastrointestinal cancers: a marker of peritoneal carcinomatosis burdenLeonardo Provenzano, Yong Xiang Gwee, Veronica Conca, et al.
Genome Medicine|October 12, 2021
Integrative epigenomic and high-throughput functional enhancer profiling reveals determinants of enhancer heterogeneity in gastric cancerTaotao Sheng, Shamaine Wei Ting Ho, Wen Fong Ooi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2020
Phase I Trial of Expanded, Activated Autologous NK-cell Infusions with Trastuzumab in Patients with HER2-positive CancersSoo-Chin Lee, Noriko Shimasaki, Joline S J Lim, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 1, 2024
Scalp cooling therapy for chemotherapy-induced hair loss in patients with breast or gynecological cancers-an Asian tertiary institution experienceVictor Guan Hui Lee, Jerold Loh, Fu Hui, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 2022
Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor-Positive Breast CancerJoline S J Lim, Andrea L A Wong, Samuel G W Ow, et al.
Therapeutic Advances in Medical Oncology|April 18, 2022
A phase 1 study of the safety, pharmacokinetics and pharmacodynamics of escalating doses followed by dose expansion of the selective inhibitor of nuclear export (SINE) selinexor in Asian patients with advanced or metastatic malignanciesJingshan Ho, Valerie Heong, Wei Peng Yong, et al.
Annals of Surgical Oncology|September 7, 2022
Outcomes of a Phase II Study of Intraperitoneal Paclitaxel plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal MetastasesDaryl K A Chia, Raghav Sundar, Guowei Kim, et al.
Pageof 15

Showing results (121-130 of 149) with videos related to

Sort By:
Pageof 15
JAMA Oncology|July 13, 2023
COVID-19 Severity and Waning Immunity After up to 4 mRNA Vaccine Doses in 73 608 Patients With Cancer and 621 475 Matched Controls in Singapore: A Nationwide Cohort StudyWei Chong Tan, Janice Yu Jin Tan, Joline Si Jing Lim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2018
Real-Time Tumor Gene Expression Profiling to Direct Gastric Cancer Chemotherapy: Proof-of-Concept "3G" TrialWei Peng Yong, Sun Young Rha, Iain Bee-Huat Tan, et al.
Oncotarget|September 1, 2016
Phase Ib/II randomized, open-label study of doxorubicin and cyclophosphamide with or without low-dose, short-course sunitinib in the pre-operative treatment of breast cancerAndrea L A Wong, Raghav Sundar, Ting-Ting Wang, et al.
Therapeutic Advances in Medical Oncology|November 6, 2024
Unveiling the prognostic significance of malignant ascites in advanced gastrointestinal cancers: a marker of peritoneal carcinomatosis burdenLeonardo Provenzano, Yong Xiang Gwee, Veronica Conca, et al.
Genome Medicine|October 12, 2021
Integrative epigenomic and high-throughput functional enhancer profiling reveals determinants of enhancer heterogeneity in gastric cancerTaotao Sheng, Shamaine Wei Ting Ho, Wen Fong Ooi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2020
Phase I Trial of Expanded, Activated Autologous NK-cell Infusions with Trastuzumab in Patients with HER2-positive CancersSoo-Chin Lee, Noriko Shimasaki, Joline S J Lim, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 1, 2024
Scalp cooling therapy for chemotherapy-induced hair loss in patients with breast or gynecological cancers-an Asian tertiary institution experienceVictor Guan Hui Lee, Jerold Loh, Fu Hui, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 2022
Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor-Positive Breast CancerJoline S J Lim, Andrea L A Wong, Samuel G W Ow, et al.
Therapeutic Advances in Medical Oncology|April 18, 2022
A phase 1 study of the safety, pharmacokinetics and pharmacodynamics of escalating doses followed by dose expansion of the selective inhibitor of nuclear export (SINE) selinexor in Asian patients with advanced or metastatic malignanciesJingshan Ho, Valerie Heong, Wei Peng Yong, et al.
Annals of Surgical Oncology|September 7, 2022
Outcomes of a Phase II Study of Intraperitoneal Paclitaxel plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal MetastasesDaryl K A Chia, Raghav Sundar, Guowei Kim, et al.
Pageof 15